Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Novartis extends TB donation

July 14, 2009 Sales and Marketing Africa, Novartis, TB

Novartis has extended its tuberculosis (TB) drug donation programme to Tanzania. Novartis has already delivered nearly 250,000 TB treatments to …
News

US approval boosts Plavix competitor

July 14, 2009 Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
News

Novartis and NHS Alliance collaborate on commissioning guides

July 14, 2009 Sales and Marketing NHS, Novartis, PBC

Novartis has teamed up with the NHS Alliance to launch a series of guides to help practice-based commissioning leaders tackle …
News

World class commissioning: 5 ways pharma can get involved

July 13, 2009 Sales and Marketing NHS, commissioning, healthcare, marketing

The NHS has set its sights unambiguously on achieving World Class Commissioning. After years of being internally-focused, the health service …
Feature

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009 Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …
News

WHO gives Cervarix green light for use in developing nations

July 10, 2009 Research and Development, Sales and Marketing Cervarix, vaccines

News

NICE to reconsider GSK’s Tyverb

July 9, 2009 Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …
News

Victoza launched in UK

July 9, 2009 Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …
News

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009 Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …
News

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009 Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
News
Eisai's new European HQ in Hatfield, Hertfordshire

Eisai opens new European HQ in the UK

July 8, 2009 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ

Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …
Feature

Sanofi moves to quell Lantus safety concerns

July 7, 2009 Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …
News

Depression warnings for Chantix and Zyban

July 7, 2009 Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …
News

PM Soc’s Digital Media Awards to highlight pioneering work

July 7, 2009 Sales and Marketing digi, pm society

UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …
News
VasellaWEB

Vasella: on leadership

July 7, 2009 Sales and Marketing Novartis, Vasella, leadership, management

Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …
Feature
The Gateway to Local Adoption Series

Latest content

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026